- Home
- ALVO vs RVI Comparison
ALVO vs RVI Comparison
Compare ALVO & RVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALVO | RVI |
|---|---|---|
| Founded | 2013 | N/A |
| Country | Luxembourg | |
| Employees | 1460 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 990.4M |
| IPO Year | N/A | 2026 |
Fundamental Metrics
Financial Performance| Metric | ALVO | RVI |
|---|---|---|
| Price | $4.17 | $35.25 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | 721.1K | ★ 816.1K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.28 | N/A |
| Revenue Next Year | $18.63 | N/A |
| P/E Ratio | $18.20 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.94 | $22.21 |
| 52 Week High | $9.94 | $77.39 |
Technical Indicators
Market Signals| Indicator | ALVO | RVI |
|---|---|---|
| Relative Strength Index (RSI) | 64.02 | 41.04 |
| Support Level | $3.09 | $24.27 |
| Resistance Level | $5.46 | $63.18 |
| Average True Range (ATR) | 0.28 | 4.50 |
| MACD | 0.11 | -2.29 |
| Stochastic Oscillator | 76.06 | 5.27 |
Price Performance
Historical ComparisonAbout ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
About RVI Robinhood Ventures Fund I Common Shares of Beneficial Interest
Robinhood Ventures Fund I is a closed-end investment company. The investment objective, the Fund will mainly invest, under normal circumstances, in a concentrated portfolio generally consisting of ten or more private companies that, in the view, are growing companies at the frontiers of their respective sectors and industries. The Fund operates as a single segment.